Raymond James analyst Felix Boeschen maintains Oshkosh (NYSE:OSK) with a Outperform and raises the price target from $105 to $110.
What 4 Analyst Ratings Have To Say About Regenxbio
Over the past 3 months, 4 analysts have published their opinion on Regenxbio (NASDAQ:RGNX) stock. These analysts are…